Session 193: The State of HCV Elimination
The IDWeek 2019 Digital Library is intended as a resource to view IDWeek sessions virtually and claim CME credit. If you plan to claim CME credit for a session, please ensure you have first watched the session video in the DIGITAL LIBRARY prior to completing the evaluation form.
Faculty and Disclosures
David Thomas, MD; Director of Infectious Diseases, Johns Hopkins, COI Disclosures: Merck, Sharpe, and Dohme: Consultant
Susanna Naggie, MD; Associate Professor, Duke University, COI Disclosures: "Abbvie: Grant/Research Support, BioMarin: Consultant, FHI360: Consultant, Gilead Sciences: Grant/Research Support, PRA: Consultant, Tacere: Grant/Research Support, Vir Biotechnology: Consultant"
Joseph Doyle, MBBS, MPH, PhD, FRACP Deputy Director, Disease Elimination Program Burnet Institute, Alfred Health and Monash University, COI Disclosures: "Abbvie: Advisory Board, Grant/Research Support, Research Grant bristol myers squibb: Research Grant Gilead Sciences, Inc.: Advisory Board, Grant/Research Support, Research Grant Merck: Advisory Board, Research Grant"
Jeffrey Lazarus, PhD, MIH, MA; Associate Research Professor ISGlobal, Hospital Clínic, University of Barcelona, COI Disclosures: "Abbvie: Advisory Board, Research Grant, CEPHEID: Speaker's Bureau Gilead Sciences: Advisory Board, Research Grant GSK: Consultant, Janssen: Advisory Board, Merck, Sharpe, and Dohme: Research Grant"
Leith States,MD, MPH, COI Disclosures: Nothing to disclose
IDSA is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit(s)™